Europe
It is one of VisiConsult’s most successful projects and is mainly sold abroad: The XRHRobotStar was honoured on May 9 in Berlin by the German Central Innovation Program for SMEs (ZIM).
Medigene AG announced that the Company’s strategic partner bluebird bio, Inc. (NASDAQ:BLUE), USA, at its analyst day presentation, will present preclinical data of the first therapeutic T cell receptor (TCR) candidate resulting from the research and development partnership with Medigene.
Corporate LiveWire acknowledges the importance of a patient-accepted CRC detection method to effectively diagnose colorectal cancer.
New funding will enable pharmaceutical group to accelerate program of international growth through acquisitions
BioArctic’s partner Eisai initiated Phase 3-study with BAN2401 in Alzheimer’s disease.
Expedeon AG reported results for the first quarter ended March 31, 2019.
Medtronic plc announced the publication of the SMILE study in The Lancet Diabetes & Endocrinology.
Epigenomics AG announced the financial results for the first quarter of the FY 2019.
Technology developed by Expedeon company TGR BioSciences
Medigene AG announced its participation at the following upcoming scientific, business development and investor conferences
PRESS RELEASES